Immune Adsorption for the Treatment of Fatigue-Dominant Long-/Post-COVID Syndrome.
作者信息
Ruhe Johannes, Giszas Benjamin, Schlosser Mandy, Reuken Philipp A, Wolf Gunter, Stallmach Andreas
出版信息
Dtsch Arztebl Int. 2023 Jul 24;120(29-30):499-500. doi: 10.3238/arztebl.m2023.0073.
Abstract
摘要
相似文献
1
Immune Adsorption for the Treatment of Fatigue-Dominant Long-/Post-COVID Syndrome.
Dtsch Arztebl Int. 2023 Jul 24;120(29-30):499-500. doi: 10.3238/arztebl.m2023.0073.
2
[Post-COVID syndrome-Focus fatigue].
Nervenarzt. 2022 Aug;93(8):788-796. doi: 10.1007/s00115-022-01306-1. Epub 2022 May 23.
3
Humility and Acceptance: Working Within Our Limits With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
J Orthop Sports Phys Ther. 2021 May;51(5):197-200. doi: 10.2519/jospt.2021.0106.
4
Fostering Fatigue-Management in People with Post-Acute COVID-19 Syndrome - Experiences with the "Untire" App.
Stud Health Technol Inform. 2022 May 16;293:47-51. doi: 10.3233/SHTI220346.
5
Long COVID: An overview.
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875. doi: 10.1016/j.dsx.2021.04.007. Epub 2021 Apr 20.
6
Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management.
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102235. doi: 10.1016/j.dsx.2021.102235. Epub 2021 Jul 28.
7
Is Cognitive Behavioural Therapy Effective for Post-COVID Fatigue?
Clin Infect Dis. 2023 Oct 5;77(7):1074-1075. doi: 10.1093/cid/ciad399.
8
Response to letter to the editor regarding "Multi-Disciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in patients with Post-Acute sequelae of SARS-CoV-2 infection (PASC)".
PM R. 2021 Dec;13(12):1439-1440. doi: 10.1002/pmrj.12719. Epub 2021 Nov 3.
9
Chronic fatigue and affective symptoms in acute and long COVID are attributable to immune-inflammatory pathways.
Psychiatry Clin Neurosci. 2023 Feb;77(2):125-126. doi: 10.1111/pcn.13514. Epub 2022 Dec 21.
10
Post COVID fatigue: Can we really ignore it?
Indian J Tuberc. 2022 Apr;69(2):238-241. doi: 10.1016/j.ijtb.2021.06.012. Epub 2021 Jun 23.
引用本文的文献
1
Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)-a single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-COVID syndrome.
Trials. 2025 Apr 3;26(1):119. doi: 10.1186/s13063-025-08825-7.
2
Effect of immunoadsorption on clinical presentation and immune alterations in COVID-19-induced and/or aggravated ME/CFS.
Mol Ther. 2025 Jun 4;33(6):2886-2899. doi: 10.1016/j.ymthe.2025.01.007. Epub 2025 Jan 10.
3
Atopy and Elevation of IgE, IgG3, and IgG4 May Be Risk Factors for Post COVID-19 Condition in Children and Adolescents.
Children (Basel). 2023 Sep 25;10(10):1598. doi: 10.3390/children10101598.
本文引用的文献
1
Immunoadsorption to treat patients with severe post-COVID syndrome.
Ther Apher Dial. 2023 Aug;27(4):790-801. doi: 10.1111/1744-9987.13974. Epub 2023 Feb 16.
2
Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study.
Infection. 2023 Apr;51(2):337-345. doi: 10.1007/s15010-022-01881-0. Epub 2022 Jul 13.
3
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection.
Front Med (Lausanne). 2021 Nov 18;8:754667. doi: 10.3389/fmed.2021.754667. eCollection 2021.
4
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.
J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100. Epub 2021 Apr 16.
5
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
PLoS One. 2018 Mar 15;13(3):e0193672. doi: 10.1371/journal.pone.0193672. eCollection 2018.
Zotero 插件